10 20 30 40 50 60 70 80 1P9T - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE 12-MAY-03 1P9T
TITLE CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR TITLE 2 DESIGN OF ANTI-SARS DRUGS
COMPND MOL_ID: 1; COMPND 2 MOLECULE: REPLICASE POLYPROTEIN 1AB; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: 3C-LIKE PROTEINASE; COMPND 5 SYNONYM: 3CL-PRO, NSP2; COMPND 6 EC: 3.4.24.-
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN CORONAVIRUS; SOURCE 3 STRAIN: SARS
KEYWDS SARS-COV, HCOV, CORONAVIRUS, TGEV, MODEL
EXPDTA THEORETICAL MODEL
AUTHOR K.ANAND,J.ZIEBUHR,P.WADHWANI,J.R.MESTERS,R.HILGENFELD
REVDAT 2 24-JUN-03 1P9T 1 JRNL REVDAT 1 20-MAY-03 1P9T 0
JRNL AUTH K.ANAND,J.ZIEBUHR,P.WADHWANI,J.R.MESTERS, JRNL AUTH 2 R.HILGENFELD JRNL TITL CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: JRNL TITL 2 BASIS FOR DESIGN OF ANTI-SARS DRUGS JRNL REF SCIENCE V. 300 1763 2003 JRNL REFN ASTM SCIEAS US ISSN 0036-8075
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1P9T COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-MAY-2003. REMARK 100 THE RCSB ID CODE IS RCSB019187.
REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: NULL
REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 48 N - CA - C ANGL. DEV. = 6.1 DEGREES REMARK 500 ASN A 53 N - CA - C ANGL. DEV. = -5.5 DEGREES REMARK 500 TYR A 54 N - CA - C ANGL. DEV. = 5.8 DEGREES REMARK 500 PRO A 132 N - CA - C ANGL. DEV. = 6.0 DEGREES REMARK 500 TYR A 161 N - CA - C ANGL. DEV. = 5.5 DEGREES REMARK 500 LEU A 202 CA - CB - CG ANGL. DEV. = 8.6 DEGREES REMARK 500 LEU A 202 N - CA - C ANGL. DEV. = 6.5 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 282 -53.44 69.27
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LVO RELATED DB: PDB REMARK 900 TRANSMISSIBLE GASTROENTERITIS VIRUS (TGEV) MAIN PROTEINASE REMARK 900 RELATED ID: 1P9S RELATED DB: PDB REMARK 900 RELATED ID: 1P9U RELATED DB: PDB
DBREF 1P9T A 1 304 UNP P59641 R1AB_CVHSA 3241 3544
SEQRES 1 A 304 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 A 304 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 A 304 LEU ASN GLY LEU TRP LEU ASP ASP THR VAL TYR CYS PRO SEQRES 4 A 304 ARG HIS VAL ILE CYS THR ALA GLU ASP MET LEU ASN PRO SEQRES 5 A 304 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS SER SEQRES 6 A 304 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 A 304 GLY HIS SER MET GLN ASN CYS LEU LEU ARG LEU LYS VAL SEQRES 8 A 304 ASP THR SER ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 A 304 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 A 304 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 A 304 ARG PRO ASN HIS THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 A 304 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 A 304 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 A 304 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY LYS PHE TYR SEQRES 15 A 304 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 A 304 THR ASP THR THR ILE THR LEU ASN VAL LEU ALA TRP LEU SEQRES 17 A 304 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 A 304 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 A 304 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 A 304 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 A 304 VAL LEU ASP MET CYS ALA ALA LEU LYS GLU LEU LEU GLN SEQRES 22 A 304 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER THR ILE SEQRES 23 A 304 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 A 304 CYS SER GLY VAL THR
HELIX 1 1 PRO A 39 ILE A 43 5 5 HELIX 2 2 ASN A 203 LEU A 208 1 6 HELIX 3 3 ASP A 229 MET A 235 1 7 HELIX 4 4 VAL A 261 ALA A 266 1 6
SHEET 1 A 2 MET A 82 GLN A 83 0 SHEET 2 A 2 LEU A 86 LEU A 87 -1 O LEU A 86 N GLN A 83 SHEET 1 B 2 PHE A 112 VAL A 114 0 SHEET 2 B 2 TYR A 126 CYS A 128 -1 O CYS A 128 N PHE A 112 SHEET 1 C 2 PHE A 150 ILE A 152 0 SHEET 2 C 2 VAL A 157 PHE A 159 -1 O SER A 158 N ASN A 151 SHEET 1 D 2 HIS A 163 GLU A 166 0 SHEET 2 D 2 HIS A 172 GLY A 174 -1 O ALA A 173 N MET A 165
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000